These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 235161)

  • 21. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
    Dennert G; Hatlen LE
    J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.
    Golding H; Rittenberg MB
    J Immunol; 1982 Nov; 129(5):1878-82. PubMed ID: 6749981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirement for macrophages in lipopolysaccharide-stimulated mixed thymocyte cultures.
    Ritter J; Lohmann-Matthes ML; Sonntag HG; Fischer H
    Cell Immunol; 1975 Mar; 16(1):153-61. PubMed ID: 123174
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 26. The destruction of allogeneic tumour cells by peritoneal macrophages from immune mice: purification of lytic effector cells.
    Boyle MD; Ormerod MG
    Cell Immunol; 1975 May; 17(1):247-58. PubMed ID: 165004
    [No Abstract]   [Full Text] [Related]  

  • 27. Generation of self-macrophage-toxic non-T cells in the MHC-homozygous F1 spleen cells co-cultured with parental cells: possible involvements of host cells in impaired immunity in GVH disease.
    Hosono M; Hosokawa T; Fujiwara M; Katsura Y
    Jpn J Exp Med; 1988 Dec; 58(6):261-7. PubMed ID: 2978270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of a cytophilic factor from challenged immune peritoneal lymphocytes in specific macrophage cytotoxicity.
    Pels E; den Otter W
    Cancer Res; 1974 Nov; 34(11):3089-94. PubMed ID: 4423930
    [No Abstract]   [Full Text] [Related]  

  • 30. Local graft-versus-host-reaction in mice specifically inhibited by anti-receptor antibodies.
    Binz H
    Scand J Immunol; 1975; 4(1):79-87. PubMed ID: 237319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of the effector cells in the cytotoxic reaction against allogeneic lymphoma cells.
    Forman J; Britton S
    J Exp Med; 1973 Feb; 137(2):369-86. PubMed ID: 4539847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic resistance in the graft-versus-host reaction.
    Sula K; Nouza K
    Exp Clin Immunogenet; 1984; 1(3):175-84. PubMed ID: 6101099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of macrophages in tumour immunity. II. Involvement of a macrophage cytophilic factor during syngeneic tumour growth inhibition.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):627-36. PubMed ID: 4563478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.
    Mann RA; Schiff D; Jetzt AE; Ron Y; Singh M; Singh AB
    Clin Immunol Immunopathol; 1998 Dec; 89(3):260-70. PubMed ID: 9837696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum.
    Basić I; Milas L; Grdina DJ; Withers HR
    J Natl Cancer Inst; 1975 Sep; 55(3):589-96. PubMed ID: 1159835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody and cell requirements for cytotoxicity by non-immune effector cells.
    Gelfand EW; Resch K
    Adv Exp Med Biol; 1973; 29(0):581-8. PubMed ID: 4604104
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of nonspecific cytotoxicity in graft-versus-host reaction as a function of target cell type.
    Singh JN; Sabbadini E; Sehon AH
    Cell Immunol; 1973 Aug; 8(2):280-9. PubMed ID: 4146905
    [No Abstract]   [Full Text] [Related]  

  • 40. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.